Han et al. [18] found that the infiltration levels of CD8+ T and NK cells were increased in mouse models of YTHDF1-deficient tumours, which enhanced the cross-expression of tumour antigens and cross-primers of CD8+ T cells in vivo. The gene discussed is CD8A; the disease is neoplasm.